BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21382904)

  • 1. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.
    Tester DJ; Ackerman MJ
    Circulation; 2011 Mar; 123(9):1021-37. PubMed ID: 21382904
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized medicine: genetic diagnosis for inherited cardiomyopathies/channelopathies.
    Ackerman MJ; Marcou CA; Tester DJ
    Rev Esp Cardiol (Engl Ed); 2013 Apr; 66(4):298-307. PubMed ID: 24775620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: a 10-year regional laboratory experience.
    Mak CM; Chen SP; Mok NS; Siu WK; Lee HH; Ching CK; Tsui PT; Fong NC; Yuen YP; Poon WT; Law CY; Chong YK; Chan YW; Yung TC; Fan KY; Lam CW
    Hong Kong Med J; 2018 Aug; 24(4):340-349. PubMed ID: 29497013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
    Ackerman MJ; Priori SG; Willems S; Berul C; Brugada R; Calkins H; Camm AJ; Ellinor PT; Gollob M; Hamilton R; Hershberger RE; Judge DP; Le Marec H; McKenna WJ; Schulze-Bahr E; Semsarian C; Towbin JA; Watkins H; Wilde A; Wolpert C; Zipes DP
    Heart Rhythm; 2011 Aug; 8(8):1308-39. PubMed ID: 21787999
    [No Abstract]   [Full Text] [Related]  

  • 5. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
    Ackerman MJ; Priori SG; Willems S; Berul C; Brugada R; Calkins H; Camm AJ; Ellinor PT; Gollob M; Hamilton R; Hershberger RE; Judge DP; Le Marec H; McKenna WJ; Schulze-Bahr E; Semsarian C; Towbin JA; Watkins H; Wilde A; Wolpert C; Zipes DP; ;
    Europace; 2011 Aug; 13(8):1077-109. PubMed ID: 21810866
    [No Abstract]   [Full Text] [Related]  

  • 6. Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association.
    Ahmad F; McNally EM; Ackerman MJ; Baty LC; Day SM; Kullo IJ; Madueme PC; Maron MS; Martinez MW; Salberg L; Taylor MR; Wilcox JE
    Circ Genom Precis Med; 2019 Jun; 12(6):e000054. PubMed ID: 31117808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies.
    Crotti L; Kotta MC
    Int J Cardiol; 2017 Jun; 237():45-48. PubMed ID: 28532586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies.
    Crotti L; Brugada P; Calkins H; Chevalier P; Conte G; Finocchiaro G; Postema PG; Probst V; Schwartz PJ; Behr ER
    Europace; 2023 Aug; 25(8):. PubMed ID: 37622577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Latest news and perspectives in cardiogenetics].
    Malagù M; Zaraket F; Gualandi F; Ferlini A; Brieda A; Vitali F; Del Franco A; Balla C; Fucili A; Ferrari R; Bertini M
    G Ital Cardiol (Rome); 2018 Feb; 19(2):91-100. PubMed ID: 29531381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnostics of cardiovascular diseases in sudden unexplained death.
    Tang Y; Stahl-Herz J; Sampson BA
    Cardiovasc Pathol; 2014; 23(1):1-4. PubMed ID: 24157219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of genetics on the clinical management of channelopathies.
    Schwartz PJ; Ackerman MJ; George AL; Wilde AAM
    J Am Coll Cardiol; 2013 Jul; 62(3):169-180. PubMed ID: 23684683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Testing for Cardiomyopathies in Clinical Practice.
    Ingles J; Bagnall RD; Semsarian C
    Heart Fail Clin; 2018 Apr; 14(2):129-137. PubMed ID: 29525642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of variant reinterpretation in inherited cardiovascular diseases: Establishing the optimal timeframe.
    Fernandez-Falgueras A; Coll M; Iglesias A; Tiron C; Campuzano O; Brugada R
    PLoS One; 2024; 19(5):e0297914. PubMed ID: 38691546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From diagnostic testing to precision medicine: the evolving role of genomics in cardiac channelopathies and cardiomyopathies in children.
    Bidzimou MK; Landstrom AP
    Curr Opin Genet Dev; 2022 Oct; 76():101978. PubMed ID: 36058060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function.
    Lehnart SE; Ackerman MJ; Benson DW; Brugada R; Clancy CE; Donahue JK; George AL; Grant AO; Groft SC; January CT; Lathrop DA; Lederer WJ; Makielski JC; Mohler PJ; Moss A; Nerbonne JM; Olson TM; Przywara DA; Towbin JA; Wang LH; Marks AR
    Circulation; 2007 Nov; 116(20):2325-45. PubMed ID: 17998470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.
    Jiménez-Jáimez J; Alcalde Martínez V; Jiménez Fernández M; Bermúdez Jiménez F; Rodríguez Vázquez Del Rey MDM; Perin F; Oyonarte Ramírez JM; López Fernández S; de la Torre I; García Orta R; González Molina M; Cabrerizo EM; Álvarez Abril B; Álvarez M; Macías Ruiz R; Correa C; Tercedor L
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):808-816. PubMed ID: 28566242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous implantable cardioverter defibrillator in cardiomyopathies and channelopathies.
    Migliore F; Pelliccia F; Autore C; Bertaglia E; Cecchi F; Curcio A; Bontempi L; Curnis A; De Filippo P; D'Onofrio A; Francia P; Maurizi N; Musumeci B; Proclemer A; Zorzi A; Corrado D
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):633-642. PubMed ID: 30222664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Channelopathies, genetic testing and risk stratification.
    Wilde AAM; Amin A
    Int J Cardiol; 2017 Jun; 237():53-55. PubMed ID: 28343764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of Incidental Genetic Findings Localizing to Genes Associated With Cardiac Channelopathies and Cardiomyopathies.
    Ezekian JE; Rehder C; Kishnani PS; Landstrom AP
    Circ Genom Precis Med; 2021 Aug; 14(4):e003200. PubMed ID: 34384235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life threatening causes of syncope: channelopathies and cardiomyopathies.
    Herman A; Bennett MT; Chakrabarti S; Krahn AD
    Auton Neurosci; 2014 Sep; 184():53-9. PubMed ID: 24795161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.